Sarah Knapton
Sarah Knapton is a journalist who has written extensively about science and health. Her work often focuses on medical breakthroughs and their potential impact on human lives. In her biography, she shares her own experience of living with oesophageal atresia, a rare congenital defect that affected her eating habits and required multiple surgeries throughout her childhood. This personal experience has likely influenced her reporting on medical advancements and their implications for individuals and families affected by various health conditions.
22%
The Daily's Verdict
This author has a poor reputation for journalistic standards and is not considered a reliable news source.
Bias
10%
Examples:
- The article seems to have a slight positive slant towards the research conducted at University College London and Great Ormond Street, but it is not overly biased.
Conflicts of Interest
0%
Examples:
No current examples available.
Contradictions
0%
Examples:
No current examples available.
Deceptions
30%
Examples:
- The article mentions that the anti-IL11 treatment made the treated mice appear sprightly with thick, glossy coats. However, it does not mention that these mice were also healthier and had a longer lifespan.
Recent Articles
Komodo Dragons' Iron-Coated Teeth: A Remarkable Adaptation for Efficient Prey Tearing and Potential Insights into Carnivorous Dinosaurs
Broke On: Wednesday, 24 July 2024Scientists discover Komodo dragons' iron-coated teeth, a remarkable adaptation for efficient prey tearing. This discovery sheds light on how carnivorous dinosaurs may have eaten and could inspire new dental techniques. Blocking Inflammatory Protein IL-11 Extends Healthy Lifespan of Mice by 25%: New Study Reveals
Broke On: Wednesday, 17 July 2024Scientists discovered that blocking the inflammatory protein IL-11 extends healthy lifespan of mice by 25%, reducing deaths from cancer and improving muscle strength. Studies conducted by MRC Laboratory of Medical Science, Imperial College London, and Duke-NUS Medical School revealed IL-11's pro-inflammatory role in aging. Anti-IL-11 treatments are currently in human clinical trials for age-related diseases.